NEW DELHI — In the global pursuit of greater pharmaceutical accessibility, Indian generic drugs have gained popularity for their affordability and broad reach, while also facing persistent challenges ...

On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

The health ministry has amended the NDCT Rules to cut approval timelines for new drug trials and testing by half, aiming to ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Bionpharma's etravirine tablet for HIV/AIDS, developed on a continuous manufacturing platform, got Abbreviated New Drug ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

The product was developed using STEERLife's FragMelt continuous processing platform, which enables solvent-free manufacturing while maintaining bioequivalence to the reference product.

Investors in biotech companies approach their investments with the mindset of praying or scratching a lottery ticket because the success rate of new drug development is extremely low, and the costs ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

By Patrick Wingrove Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the ...

With ANDA approval secured, Bionpharma will lead the commercialization and distribution of Etravirine tablets in the United States. Both organizations view this achievement as a solid foundation for ...